These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8161007)

  • 1. Platelet-derived growth factor (PDGF) in patients with different degrees of chronic arterial obstructive disease.
    Cimminiello C; Arpaia G; Aloisio M; Uberti T; Rossi F; Pozzi F; Bonfardeci G
    Angiology; 1994 Apr; 45(4):289-93. PubMed ID: 8161007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of tumor necrosis factor and endothelial response in patients with chronic arterial obstructive disease or Raynaud's phenomenon.
    Cimminiello C; Arpaia G; Toschi V; Rossi F; Aloisio M; Motta A; Bonfardeci G
    Angiology; 1994 Dec; 45(12):1015-22. PubMed ID: 7985828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs.
    Mangiafico RA; Malatino LS; Santonocito M; Spada RS
    Int Angiol; 1998 Jun; 17(2):97-102. PubMed ID: 9754897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages.
    Mangiafico RA; Malatino LS; Santonocito M; Sarnataro F; Dell'Arte S; Messina R; Santangelo B
    Panminerva Med; 1999 Mar; 41(1):22-6. PubMed ID: 10230252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage IIb.
    Mangiafico RA; Malatino LS; Spada RS; Santonocito M; Messina R; Dell'Arte S; Attinà T
    Int Angiol; 2000 Mar; 19(1):14-7. PubMed ID: 10853680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of platelet derived growth factor concentration in post myocardial infarction and stable angina patients.
    Wallace JM; Freeburn JC; Gilmore WS; Sinnamon DG; Craig BM; McNally RJ; Strain JJ
    Ann Clin Biochem; 1998 Mar; 35 ( Pt 2)():236-41. PubMed ID: 9547894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor and growth-promoting activity in the serum samples and platelets of patients with non-insulin-dependent diabetes mellitus.
    Nakashima N; Umeda F; Yamauchi T; Ishii H; Hisatomi A; Nawata H; Masuko H; Nakayama K; Tatematsu A
    J Lab Clin Med; 1992 Jul; 120(1):78-85. PubMed ID: 1613332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease.
    Poredos P; Stegnar M; Gacnik A
    Vasa; 1999 May; 28(2):106-11. PubMed ID: 10409921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure.
    Takayama H; Miyake Y; Nouso K; Ikeda F; Shiraha H; Takaki A; Kobashi H; Yamamoto K
    J Gastroenterol Hepatol; 2011 Jan; 26(1):116-21. PubMed ID: 21175804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung.
    Homma S; Nagaoka I; Abe H; Takahashi K; Seyama K; Nukiwa T; Kira S
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2084-9. PubMed ID: 8520779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease].
    Aligne C; Mosnier M; Mistretta F; Larguier JS
    J Mal Vasc; 2000 Jun; 25(3):187-94. PubMed ID: 10906634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid.
    Vissinger H; Husted SE; Kristensen SD; Nielsen HK
    Angiology; 1993 Aug; 44(8):633-8. PubMed ID: 8342880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma.
    Tsirakis G; Pappa CA; Kanellou P; Stratinaki MA; Xekalou A; Psarakis FE; Sakellaris G; Alegakis A; Stathopoulos EN; Alexandrakis MG
    Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.
    Riccieri V; Stefanantoni K; Vasile M; Macrì V; Sciarra I; Iannace N; Alessandri C; Valesini G
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S46-52. PubMed ID: 21586218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
    Blardi P; de Lalla A; Pieragalli D; De Franco V; Meini S; Ceccatelli L; Auteri A
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):175-82. PubMed ID: 16939882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Allegra C; Pollari G; Carioti B; Sardina M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):646-51. PubMed ID: 7881702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication.
    Mika P; Wilk B; Mika A; Marchewka A; Nizankowski R
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):754-60. PubMed ID: 21450630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay of platelet-derived growth factor in the blood of patients with diabetes mellitus.
    Harrison AA; Dunbar PR; Neale TJ
    Diabetologia; 1994 Nov; 37(11):1142-6. PubMed ID: 7867886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.